New mechanoresistant cancer cells show how they survive high stress environments
Rice bioengineer Michael King and his team recently published a paper demonstrating that this ability to survive high-stress environments, or mechanoresistance, can be induced in prostate cancer cells.
Rice and NASA launch world’s first open-source remote space robotics simulator
Researchers at NASA and Rice have launched the the world’s first open-source dynamic simulation environment to develop robots used in space vehicles and indoor space habitats.
Listening through a network: A new view of how the cochlea processes sound
Rice researchers developed a new way to model how the cochlea processes incoming sound using graph signal processing, which could shed light on what happens as hearing deteriorates with age and make possible better assistive technologies for people with hearing loss.
Rice bioengineer wins federal award for Ewing sarcoma research
Rice bioengineer Julea Vlassakis has won $1.1M in federal funding for a project researching Ewing sarcoma.
RNA barcoding approach reveals previously unknown virus-host relationships
An interdisciplinary team of Rice researchers has uncovered previously unknown relationships between bacteriophages and their bacterial hosts, offering a powerful new tool for next-generation microbiome engineering.
New CPRIT awards expand Rice cancer research efforts
New funding from CPRIT will help Rice advance cancer research on several fronts, from strengthening a core genetic engineering facility that serves researchers across Texas to supporting new studies in cancer immunotherapy, next-generation radiation therapy and ovarian cancer.
Study is first demonstration of gene transcription measurement in the living brain
Bioengineers at Rice have developed a way to map DNA transcription profiles in living brain tissue with great accuracy based solely on a blood sample.
Living bandage accelerates healing across multiple wound types
Researchers developed a living bandage that accelerated healing across several wound types in animal models by continuously releasing therapeutic proteins at injury sites.
Rice researchers develop realistic ‘mock’ samples to speed cervical cancer test development
A team of Rice bioengineers has developed a new way to create highly realistic “mock” patient samples that could help accelerate the development of faster, more accessible cervical cancer screening tests for low-resource settings.
First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
Rice researchers and collaborators at MD Anderson report results from a first-in-human trial evaluating a novel cell-based therapeutic platform in patients with advanced ovarian cancer.
AI-powered handheld microscope aims to spot cancer earlier
Researchers at Rice and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer.
Rice bioengineering outreach event brings Houston students into the lab
Nearly 70 high school students from across the Houston area spent a weekend morning moving through different research labs at Rice University in order to get a firsthand view of what pursuing a professional path in science and engineering could entail.
Brain-computer interface based on Rice research wins FDA approval for first clinical trial
Motif Neurotech, a company commercializing technology based on research at Rice, has received approval from the FDA to begin the first clinical trial of its therapeutic brain-computer interface for treatment of treatment-resistant depression.
The Rice Biotech Launch Pad will advance the development of a cell-based therapy for Type 1 diabetes supported by an award from Breakthrough T1D.
An internal seed funding initiative will support 12 projects exploring brain health research.
